KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) FCF Margin (2016 - 2025)

Historic FCF Margin for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 20.15%.

  • Abbott Laboratories' FCF Margin fell 600.0% to 20.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.78%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 15.14% for FY2024, which is 25300.0% up from last year.
  • As of Q3 2025, Abbott Laboratories' FCF Margin stood at 20.15%, which was down 600.0% from 13.87% recorded in Q2 2025.
  • Abbott Laboratories' 5-year FCF Margin high stood at 22.29% for Q4 2023, and its period low was 6.29% during Q1 2024.
  • Over the past 5 years, Abbott Laboratories' median FCF Margin value was 17.01% (recorded in 2022), while the average stood at 16.05%.
  • As far as peak fluctuations go, Abbott Laboratories' FCF Margin soared by 168300bps in 2021, and later crashed by -110700bps in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' FCF Margin stood at 21.39% in 2021, then fell by -20bps to 17.01% in 2022, then soared by 31bps to 22.29% in 2023, then decreased by -12bps to 19.57% in 2024, then grew by 3bps to 20.15% in 2025.
  • Its last three reported values are 20.15% in Q3 2025, 13.87% for Q2 2025, and 9.01% during Q1 2025.